Search Results

Summary This antibody recognizes the SC5b-9 complex of around 330 kDa. Both the classical and alternative complement pathways result in the formation of the cytolysis inducing C5b-9 complex. This complex is composed of 190 kDa C5b, which is bound to cells via 71 kDa C9. Sublytic assembly of C5b-9 on plasma membranes induces cell cycle activation and survival. The binding of C5b-9 to the 75 kDa S-protein (or vitronectin) in the fluid phase prevents C5b-9 from assembling on the plasma membrane, deactivating it and forming the SC5b-9 complex. SC5b-9 is stable in vitro and is, therefore, a reliable indicator of terminal complement pathway activation.

Summary This antibody recognizes both native and recombinant bovine IFN gamma.

Summary This antibody recognizes the Bb fragment of 90 kDa human complement factor B.

Summary The monoclonal antibody 7E9 recognizes mouse complement receptors type 1 (CR1) and 2 (CR2). This clone does not inhibit rosette formation between 2PK3 cells and Crd-coated SRBC indicator cells.

Summary This antibody recognizes the long and short forms CD158a and CD158b (KIR2DL, KIR2DS1 and KIR2DS2 respectively) and also p50.3 (KIR2DS4).

Summary Peptide sequence is < 50 % identical to other human chemokine receptors in this region.
We do not recommend use of this product for Human.